BU
ELV icon

BBVA USA’s Elevance Health ELV Stock Holding History

BBVA USA’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$36K Sell
97
-14
-13% -$5.32K ﹤0.01% 704
2021
Q2 		$42K Buy
+111
New +$42.4K ﹤0.01% 698

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BBVA USA's ELV Position: Q3 2021 in Review

BBVA USA reduced its Elevance Health (ELV) stake by 13% in Q3 2021, selling an estimated $5.32K and leaving 97 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

BBVA USA first reported a position in ELV in Q2 2021 and has held it in 2 quarters since. The position peaked at $42K in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • BBVA USA held 97 shares of Elevance Health worth $36K as of Q3 2021.
  • BBVA USA sold 14 Elevance Health shares in Q3 2021, an estimated $5.32K.
  • Elevance Health made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #704 holding.
  • BBVA USA first reported a position in Elevance Health in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Elevance Health position peaked at $42K in Q2 2021.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.